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March 4, 2008:968–73ross-sections, additional special factors, such as discontinuation of
ntiplatelet therapy, antiplatelet resistance, intrinsic thromboge-
icity, or coronary flow problems might trigger the development
f LST.
In comparison with previous data of 3-month follow-up (pa-
ients n 21, struts n 4,545) (3), thickness of NIH in the 2-year
ollow-up group was greater than that in the 3-month follow-up
roup (71  93 m vs. 29  41 m, respectively; p  0.00001).
requency of uncovered struts was lower in the 2-year group than
n the 3-month group (5% vs. 15%, respectively; p  0.00001).
oreover, the prevalence of patients with cross-section(s) of
ncovered strut ratio 0.3 was lower in the 2-year group than in
he 3-month group (38% vs. 76%, respectively) (Fig. 2). Clinical
haracteristics were similar between the 2 groups. From this
erspective, neointimal coverage inside the SES progressed, and
ncovered stent struts decreased from 3-month to 2-year follow-
p. In contrast, prevalence of patients with uncovered struts did
ot differ between the 3-month group and the 2-year group (95%
s. 81%, respectively) (Fig. 2). Despite the fact that neointimal
overage advanced, a few troublesome stent struts might persist as
ncovered struts for up to 2 years.
Two thrombi inside the SES were identified in patients who did
ot have an uncovered strut. Cross-sectional OCT images might
ave a limitation in identification of the uncovered struts under
n-stent thrombi. Intracoronary structures inside the SES, except
or distinct thrombi, were regarded as NIH in this OCT analysis.
owever, it was possible that some tissue of fluffy appearance
Fig. 1) was not NIH but was actually fibrin deposition. Unfortu-
ately, no method of distinguishing fibrin layer from NIH around
he struts in living patients has been established. Additionally,
here is no confirmation that morphological intracoronary struc-
ures have mature endothelial function, such as an antithrombotic
unction. Although OCT is used, evaluation for the uncovered
truts might be underestimated in the situation of fibrin deposition
Figure 2 Prevalence of Patients With Uncovered Struts
The prevalence of patients with uncovered strut(s) did not differ between the
3-month follow-up group (blue bars) and the 2-year follow-up group (yellow
bars). In contrast, prevalence of patients with cross-section(s) of uncovered
strut ratio 0.3 was lower in the 2-year group than in the 3-month group.r thrombus adhesion to the struts. dIn conclusion, long-term follow-up OCT examination demon-
trated that few uncovered struts remained in the majority of the
atients for up to 2 years after SES implantation. Further careful
ollow-up might be required.
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Letters to the Editor
-Wave Alternans
nd Intraventricular
onduction Delays
read with great interest the study by Cantillon et al. (1) on the
tility of microvolt T-wave alternans (MTWA) in predicting total
ortality and arrhythmia-free survival in patients with a left
entricular ejection fraction 30% who had been referred for
nvasive electrophysiological testing for evaluation of syncope
nd/or nonsustained ventricular tachycardia. It is not clear to this
eader whether this report’s database derives from the one em-
loyed in another study, emanating from the same laboratory, and
ublished in another journal on the same month as the present
tudy (2). However, even if this is the case, the present study
rovides an opportunity to evaluate the influence of the QRS
uration on the magnitude of the MTWA. The authors in both
tudies (1,2) employed the traditional threshold of 1.9 V,
erived from the spectral analysis of the signal, to characterize an
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March 4, 2008:968–73TWA value as positive. Although this analysis operates on this
ichotomy to generate the “positive” and the “negative” response of
patient to MTWA testing, thus creating a qualitative context,
here is a quantitative issue as its underpinning (i.e., a patient has
o reach the threshold to qualify as “positive”). Moreover, current
ork indicates that the magnitude in V of MTWA may be of
mportance, and higher values of calculated MTWA may imply
orse prognosis (3,4), or therapy with various drugs, particularly
eta-blockers, may attenuate the magnitude of MTWA (5).
owever, more work is needed to substantiate the claim that the
uantitative assessment of MTWA may have advantages over the
ualitative evaluation. In the meantime, it is important to deal with
ome possible confounders of the quantitative employment of the
TWA, 1 of which may be its T-wave amplitude dependence (6).
ccordingly, in the presence of ventricular conduction delays,
hich often are associated with T waves larger in amplitude than
he ones encountered in association with normal intraventricular
onduction, a greater magnitude of MTWA in the former than in
he latter may not mean a higher risk for sudden cardiac death or
alignant ventricular arrhythmia, but merely an enhancing effect
f the taller T waves on the magnitude of MTWA in patients with
ide QRS complexes. Probably this was the reason for the
ncreased rate of false-positive MTWA tests in patients with wide
RS complexes (120 ms) (specificity 22% in the patients with a
ide QRS and 40% in the patients with a narrow QRS) in the
uthors’ other report (2). In that report they categorized their
atients to those with QRS duration of 120 ms and 120 ms
2). In their present contribution (1), by employing 3 categories of
atients in terms of QRS duration (Table 1) (QRS110 ms, QRS
10 ms to 120 ms, and QRS 120 ms), they provide an
pportunity to evaluate the effect of the amplitude of the T waves
n the magnitude of MTWA in a “dose response” fashion. What
s needed for this is a comparison of the values of MTWA in V,
nd the T-wave amplitudes in mV in the above 3 categories of
atients, according to their QRS duration. Could the authors
rovide us with these data? Evaluation of possible determinants of
he MTWA and potential adjustment via a MTWA index (6) may
pgrade both the currently used “qualitative” assessment and a
uture adoption of quantitative assessment of MTWA testing.
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ercutaneous
ntervention in Saphenous
ein Bypass Graft Disease
ase Against the Use
f Drug-Eluting Stents
aphenous vein grafts (SVGs) tend to degenerate over time, and
lmost one-half develop significant stenosis and nearly 40% are
ompletely occluded within 1 decade (1). Use of balloon angio-
lasty alone without stenting for treatment of SVG disease is
ssociated with poor short-term and long-term outcome (2). Use
f bare-metal stents (BMS) is associated with restenosis rates as
igh as 50% at 6 months (3). Lately, drug-eluting stents (DES)
ave been used for the treatment of SVG disease.
In contrast to the native coronary arteries, in which restenosis after
ercutaneous coronary intervention (PCI) is mainly due to intimal
yperplasia, restenosis in SVG involves cellular hyperplasia, progres-
ion of atherosclerosis, local inflammatory reaction to stent struts, and
hrombosis. These observations suggest that it may not be wise to
xtend the seemingly better short- and midterm results seen with PCI
or treatment of native coronary artery disease to the treatment of
VG disease.We have recently looked at the data in our institution in
09 patients with SVG disease who received BMS or DES. During
follow-up period of 33 months, we found that the incidence of
Figure 1 Kaplan-Meier Survival Curves for
Freedom From MACE at Almost 3 Years Follow-Up
BMS  bare-metal stents; DES  drug-eluting
stents; MACE  major adverse cardiac events.
